Additional file 3: of The neoepitope landscape of breast cancer: implications for immunotherapy



Figure S1. Frequently mutated genes in TCGA breast cancer data. Here we show the mo for: (A) ER/PR(+)HER-2(â ) breast cancers, (B) HER-2(+) breast cancers, and (C) TNBC. The % Mutant indicates the percentage of samples with a mutation in the annotated particular gene (PDF 179 kb)
Date made availableMar 4 2019
Publisherfigshare Academic Research System

Cite this